SCHEMBL822671

SCHEMBL822671

CC1CCC(NC(=O)c2ccc3c4c(ccc(OC=O)c24)C(=O)N(C2CCCCC2)C3=O)CC1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 10/20 0.41
NPSR1 Q6W5P4 2/20 0.41
ATM Q13315 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
HPGD P15428 3/20 0.39
KDM4E B2RXH2 3/20 0.39
TAS1R3 Q7RTX0 2/20 0.39
TAS1R1 Q7RTX1 2/20 0.39
TAS1R2 Q8TE23 2/20 0.39
HSD17B10 Q99714 2/20 0.39
MEN1 O00255 2/20 0.38
KMT2A Q03164 2/20 0.38
MAPK1 P28482 1/20 0.37
TSHR P16473 1/20 0.37
CNR2 P34972 3/20 0.37
NPC1 O15118 1/20 0.36
RAB9A P51151 1/20 0.36
CNR1 P21554 2/20 0.36
LMNA P02545 2/20 0.36
MAPT P10636 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL822558 0.96 ALDH1A1 (0.39) ALDH1A1NPSR1ATMSMN1; SMN2HPGD
SCHEMBL12038237 0.84 ALDH1A1 (0.43) ALDH1A1NPSR1ATMSMN1; SMN2HPGD
SCHEMBL12021834 0.84 TAS1R3 (0.46) ALDH1A1NPSR1ATMSMN1; SMN2HPGD
SCHEMBL822488 0.82 CNR2 (0.41) ALDH1A1CNR2CNR1
SCHEMBL823141 0.80 ALDH1A1 (0.43) ALDH1A1NPSR1ATMSMN1; SMN2HPGD
SCHEMBL822451 0.80 ALDH1A1 (0.43) ALDH1A1NPSR1SMN1; SMN2HPGDKDM4E
SCHEMBL822567 0.79 KMT2A (0.42) ALDH1A1SMN1; SMN2KDM4EHSD17B10MEN1
SCHEMBL12021826 0.78 TAS1R3 (0.48) ALDH1A1HPGDTAS1R3TAS1R1TAS1R2
SCHEMBL12039528 0.78 TAS1R3 (0.45) TAS1R3TAS1R1TAS1R2TSHRCNR2
SCHEMBL12067680 0.77 CNR2 (0.46) TAS1R3TAS1R1TAS1R2CNR2NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8530270-B2 Methods of preparing semiconductive compositions and devices EASTMAN KODAK COMPANY (US) 2013-09-10 US disclosed
US-8411489-B2 Semiconducting devices and methods of preparing EASTMAN KODAK COMPANY (US) 2013-04-02 US disclosed
US-8314265-B2 Aromatic amic acids or amic esters and compositions EASTMAN KODAK COMPANY (US) 2012-11-20 US disclosed
US-20110269967-A1 AROMATIC AMIC ACIDS OR AMIC ESTERS AND COMPOSITIONS BANK OF AMERICA, N.A., AS AGENT 2011-11-03 US disclosed
US-20110269265-A1 METHODS OF PREPARING SEMICONDUCTIVE COMPOSITIONS AND DEVICES KODAK REALTY INC. 2011-11-03 US disclosed
US-20110266523-A1 SEMICONDUCTING DEVICES AND METHODS OF PREPARING BANK OF AMERICA, N.A., AS AGENT 2011-11-03 US disclosed
US-20110269966-A1 SEMICONDUCTING ARTICLES CITICORP NORTH AMERICA, INC., AS AGENT 2011-11-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110269966-A1 SEMICONDUCTING ARTICLES ALAD, PORCN, DDC ALDH1A1 508/4885NPSR1 4457/4885ATM 1211/4885
US-20110269967-A1 AROMATIC AMIC ACIDS OR AMIC ESTERS AND COMPOSITIONS DDC, AADAC, MYOC ALDH1A1 745/4885NPSR1 4776/4885ATM 1245/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.